Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-005575

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Aug 19, 2016
Accepted (ET)
Aug 23, 2016 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Aug 19, 2016P100$5.50A45,696IBy: Separately Managed Account
Common StockF1,F4Aug 19, 2016P897$6.51A45,796IBy: Separately Managed Account
Common StockF1,F4Aug 22, 2016P26$6.51A45,822IBy: Separately Managed Account
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses